Atomwise Stock

atomwise.comHealthcare / BioTech & PharmaFounded: 2012Funding to Date: $331.55MM

Atomwise is the developer of first deep learning technology designed for structure-based small molecule drug discovery.

Register To Buy and Sell Shares

For more details on financing and valuation for Atomwise, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Atomwise’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Atomwise.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Izhar Wallach Ph.D
Co-Founder & Chief Technology Officer
Han Lim
Vice President and Global Head of Partnering
Abraham Heifets Ph.D
Co-Founder & Chief Executive Officer

Board Members

Gavin Teo
B Capital Group
Adam Seabrook
B Capital Group
Kiersten Stead Ph.D
Monsanto Growth Ventures
Matthew Ocko
Data Collective

Frequently Asked Questions About Atomwise’s Stock

Can you buy Atomwise’s stock?
Atomwise is not publicly traded on NYSE or NASDAQ in the U.S. To buy Atomwise’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Atomwise’s stock?
Yes, you can sell stock of a private company like Atomwise. Forge can help you sell your Atomwise stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Atomwise’s stock price?
Atomwise is a privately held company and therefore does not have a public stock price. However, you may access Atomwise’s private market stock price with Forge Data.
What is Atomwise’s stock ticker symbol?
Atomwise does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Atomwise raises $123 million to accelerate drug discovery with AI
Atomwise, a company leveraging AI and machine learning to accelerate drug discovery, has raised $123 million in venture capital.
Atomwise's X-37 spinout gets $14.5 million to launch AI discovery efforts
The folks behind Atomwise's spinout X-37 like to think in cosmological metaphors, and you can think of their AI drug development model as probes sent into space from a central station. That station just got $14.5 million in Series A funding from DCVC Bio, Alpha Intelligence Capital and Hemi Ventures
Atomwise Raises $45 Million Series A to Become the Preferred Artificial Intelligence Partner for the Global Pharmaceutical Industry
Updated on: Apr 13, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.